Avid Bioservices Inc (CDMO)

[BioBS2012]

that Opdivo trial was not double blinded.. right? N= 272 also... correct?

That is correct, see below.

https://clinicaltrials.gov/ct2/show/NCT01642004?term=checkmate&rank=15

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: An Open-Label Randomized Phase III Trial of BMS-936558 (Nivolumab) Versus Docetaxel in Previously Treated Advanced or Metastatic Squamous Cell Non-small Cell Lung Cancer (NSCLC)